A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.26
C 32.83
GOOG 604.91
BAC 8.05
RIMM 15.42

Recently Added

CPIC 1.20
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.83

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.20
NBTH 12.50
AVEW 0.00
94.81 +0.00 (0.00%) DNA

Click Here to Receive Instant E-mail and RSS Alerts


Trade DNA now with

Stock Details

Last Trade:94.81 Change:+0.00 (0.00%) Prev Close:94.81 Open: 94.81 Days Range:94.81 – 94.81 52 Week Range: 69.17 - 99.14 Volume:6877884 P/E: 29.54
EPS:3.21





Recent Blog Posts

Blog Posts on 02/14/11 at 6:05am
As Seattle Genetics Strengthens Its Foothold Within Genentech, What About Immunogen?
Blog Posts on 01/07/11 at 5:06pm
FDA: Cost Not a Factor in Avastin Decision
Blog Posts on 10/05/10 at 12:27pm
Can Array BioPharma Attract Yet Another Partner?
Blog Posts on 10/04/10 at 4:17am
Array Biopharma: A Wall Street Anomaly
Blog Posts on 10/01/10 at 10:22am
Seattle Genetics and Immunogen: Fabless Biotechs?
Blog Posts on 09/13/10 at 9:56am
ImmunoGen Suffers From the Second Lethal Virus
Blog Posts on 09/12/10 at 1:14pm
GSK's Diabetes Drug Continues to Face Scrutiny: Biotech's Latest Mishaps
Blog Posts on 08/30/10 at 8:43am
FDA Committee Rejects Expanded Use of Jazz Drug on Abuse Concerns: Biotech's Latest Failures
Blog Posts on 08/29/10 at 7:41am
Big Pharma: Why In-Licensing Is Not the Cure
Blog Posts on 08/25/10 at 3:54am
Analyzing Generex and Throwing Darts With Pfizer's Craig Eagle
Blog Posts on 08/17/10 at 9:05am
FDA Rightfully Rethinks Approval for Genentech / Roche Breast Cancer Drug
Blog Posts on 08/08/10 at 8:34am
Two IPOs Brave the Markets, Two Enter the Queue: Biotech's Latest Deals
Blog Posts on 07/28/10 at 4:48am
Big Biotech: End of an Era
Blog Posts on 07/12/10 at 8:39am
Monoclonal Antibody Companies Command Premiums
Blog Posts on 07/11/10 at 4:16am
Genentech's New Option for Breast Cancer Patients
Blog Posts on 06/20/10 at 3:59am
Curis Tumbles on Failure of Cancer Drug Trial: Biotech's Latest Mishaps
Blog Posts on 06/02/10 at 3:28am
Roche Leads the Way in Personalized Medicine
Blog Posts on 05/03/10 at 5:36pm
Will Biosimilars Alter Biotech Landscape?
Blog Posts on 04/28/10 at 12:58pm
Google Handing It Out for Free While Microsoft Suffers
Blog Posts on 04/14/10 at 4:34am
Generex's Antigen Express: Creating the Next Generation of Cancer Immunotherapy
Blog Posts on 03/28/10 at 5:40am
Jury Finds Pfizer Guilty in Racketeering Case: Biotech's Latest Mishaps
Blog Posts on 03/23/10 at 3:28am
Big Pharma: M&A Targets and a Pfizer Problem
Blog Posts on 02/21/10 at 5:28am
Dendreon Redux
Blog Posts on 02/19/10 at 3:34am
7 Reasons Curis Is Worth the Risk
Blog Posts on 12/20/09 at 7:10am
Seattle Genetics Gets Boost from Cancer Drug Deal with Takeda
Blog Posts on 12/20/09 at 7:08am
This Week's Failed Trials, Missed Targets in Biotech
Blog Posts on 12/06/09 at 10:13am
How Do the Best Performing Stocks of Decade Compare to Predictions in 2000?
Blog Posts on 12/01/09 at 2:41pm
The Ugly Decade
Blog Posts on 11/05/09 at 5:34am
Cramer's Mad Money - Distressed Tessera (11/4/09)
Blog Posts on 09/15/09 at 6:40am
Biotech ETFs Lift Portfolios Higher Than Broad-Based Healthcare ETFs